E902-0073 Screening compound: 3-(2-{1,4-dioxa-8-azaspiro[4.5]decan-8-yl}-2-oxoethyl)-8-methyl-3H,4H,5H-pyridazino[4,5-b]indol-4-one

E902-0073 Screening compound: 3-(2-{1,4-dioxa-8-azaspiro[4.5]decan-8-yl}-2-oxoethyl)-8-methyl-3H,4H,5H-pyridazino[4,5-b]indol-4-one
E902-0073 Screening compound: 3-(2-{1,4-dioxa-8-azaspiro[4.5]decan-8-yl}-2-oxoethyl)-8-methyl-3H,4H,5H-pyridazino[4,5-b]indol-4-one alternative view

Chemical Structure Depiction of ChemDiv screening compound E902-0073
3-(2-{1,4-dioxa-8-azaspiro[4.5]decan-8-yl}-2-oxoethyl)-8-methyl-3H,4H,5H-pyridazino[4,5-b]indol-4-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E902-0073

Molecular Formula

C20H22N4O4 (C20 H22 N4 O4)

Compound Name

3-(2-{1,4-dioxa-8-azaspiro[4.5]decan-8-yl}-2-oxoethyl)-8-methyl-3H,4H,5H-pyridazino[4,5-b]indol-4-one

IUPAC name

3-(2-{14-dioxa-8-azaspiro[4.5]decan-8-yl}-2-oxoethyl)-8-methyl-3H4H5H-pyridazino[45-b]indol-4-one

SMILES

Cc(cc1)cc2c1[nH]c1c2C=NN(CC(N(CC2)CCC22OCCO2)=O)C1=O

InChI

InChI=1S/C20H22N4O4/c1-13-2-3-16-14(10-13)15-11-21-24(19(26)18(15)22-16)12-17(25)23-6-4-20(5-7-23)27-8-9-28-20/h2-3,10-11,22H,4-9,12H2,1H3

InChI Key

MAYWBDCELCDPEM-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14926833

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

382.42

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

0.738

Distribution Coefficient, logD

0.738

Water Solubility, LogSw

-2.21

Polar Surface Area

69.270

Acid Dissociation Constant (pKa)

14.38

Base Dissociation Constant (pKb)

1.07

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

45.00

E902-0073 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

DGK Inhibitors Library (10558 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with E902-0073 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E902-0073?
Check Price and Availability of E902-0073, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E902-0073 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E902-0073
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E902-0073
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E902-0073 available by request